Table 2.
p value | Odds ratio | 95% CI | ||
---|---|---|---|---|
MRI referral | noMRI | Reference | – | – |
Screening MRI | < 0.001 | 2.5 | 1.5–4.0 | |
Diagnostic MRI | 0.300 | 1.2 | 0.9–1.5 | |
Preoperative MRI | < 0.001 | 2.2 | 1.9–2.5 | |
Breast density | ACR BI-RADS class a | Reference | – | – |
ACR BI-RADS class b | 0.498 | 1.1 | 0.9–1.4 | |
ACR BI-RADS class c | 0.168 | 1.2 | 0.9–1.5 | |
ACR BI-RADS class d | 0.001 | 1.7 | 1.2–2.3 | |
Breast cancer risk | Familial breast cancer risk | 0.012 | 2.0 | 1.2–3.3 |
Hormonal status | Postmenopausal | Reference | – | – |
Premenopausal | < 0.001 | 1.6 | 1.4–1.9 | |
Perimenopausal | 0.247 | 1.2 | 0.9–1.5 | |
Lesion focus at DM | No observable lesion | Reference | – | – |
Single focus | < 0.001 | 0.7 | 0.5–0.8 | |
Multifocal | 0.211 | 1.2 | 0.9–1.7 | |
Multicentric | 0.001 | 2.4 | 1.4–4.2 | |
Largest lesion diameter at DM | ≥ 20 mm | < 0.001 | 2.0 | 1.7–2.4 |
Lesion focus at US | No observable lesion | Reference | – | – |
Single focus | 0.336 | 0.9 | 0.7–1.1 | |
Multifocal | < 0.001 | 2.4 | 1.8–3.3 | |
Multicentric | < 0.001 | 5.8 | 3.2–10.8 | |
Largest lesion diameter at US | ≥ 20 mm | < 0.001 | 2.1 | 1.7–2.5 |
Core-needle or vacuum-assisted biopsy | Pure DCIS | 0.196 | 1.1 | 0.9–1.4 |
Lobular component | < 0.001 | 1.7 | 1.4–2.1 |
CI, confidence interval; ACR BI-RADS, American College of Radiology Breast Imaging Data and Reporting System; DM, digital mammography; US, ultrasonography; MRI, magnetic resonance imaging; DCIS, ductal carcinoma in situ